You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 9, March 6, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (124)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Neurology
 •Cognitive Disorders
 •Alert me on articles by topic

Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment

Nadia Solowij, PhD; Robert S. Stephens, PhD; Roger A. Roffman, DSW; Thomas Babor, PhD, MPH; Ronald Kadden, PhD; Michael Miller, PhD; Kenneth Christiansen, PsyD; Bonnie McRee, MPH; Janice Vendetti, MPH; for the Marijuana Treatment Project Research Group

JAMA. 2002;287:1123-1131.

Context  Cognitive impairments are associated with long-term cannabis use, but the parameters of use that contribute to impairments and the nature and endurance of cognitive dysfunction remain uncertain.

Objective  To examine the effects of duration of cannabis use on specific areas of cognitive functioning among users seeking treatment for cannabis dependence.

Design, Setting, and Participants  Multisite retrospective cross-sectional neuropsychological study conducted in the United States (Seattle, Wash; Farmington, Conn; and Miami, Fla) between 1997 and 2000 among 102 near-daily cannabis users (51 long-term users: mean, 23.9 years of use; 51 shorter-term users: mean, 10.2 years of use) compared with 33 nonuser controls.

Main Outcome Measures  Measures from 9 standard neuropsychological tests that assessed attention, memory, and executive functioning, and were administered prior to entry to a treatment program and following a median 17-hour abstinence.

Results  Long-term cannabis users performed significantly less well than shorter-term users and controls on tests of memory and attention. On the Rey Auditory Verbal Learning Test, long-term users recalled significantly fewer words than either shorter-term users (P = .001) or controls (P = .005); there was no difference between shorter-term users and controls. Long-term users showed impaired learning (P = .007), retention (P = .003), and retrieval (P = .002) compared with controls. Both user groups performed poorly on a time estimation task (P<.001 vs controls). Performance measures often correlated significantly with the duration of cannabis use, being worse with increasing years of use, but were unrelated to withdrawal symptoms and persisted after controlling for recent cannabis use and other drug use.

Conclusions  These results confirm that long-term heavy cannabis users show impairments in memory and attention that endure beyond the period of intoxication and worsen with increasing years of regular cannabis use.


Author Affiliations: National Drug and Alcohol Research Centre, University of New South Wales, Sydney, and Department of Psychology, University of Wollongong, Wollongong (Dr Solowij), New South Wales, Australia; Department of Psychology, Virginia Polytechnic Institute and State University, Blacksburg, Va (Dr Stephens); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (Dr Roffman); Department of Community Medicine (Dr Babor and Mss McRee and Vendetti) and Department of Psychiatry (Dr Kadden), University of Connecticut Health Center, Farmington; and The Village South Inc, Miami, Fla (Drs Miller and Christiansen).


RELATED ARTICLES

Cannabis, Cognition, and Residual Confounding
Harrison G. Pope, Jr
JAMA. 2002;287(9):1172-1174.
EXTRACT | FULL TEXT  

March 6, 2002
JAMA. 2002;287(9):1193-1194.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple Sclerosis, Cannabinoids, and Cognition
Papathanasopoulos et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:36-51.
ABSTRACT | FULL TEXT  

Neuropsychological deficits in long-term frequent cannabis users
Accordino et al.
Neurology 2006;67:1902-1902.
FULL TEXT  

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
Wade et al.
Mult Scler 2006;12:639-645.
ABSTRACT  

Brain Neuroimaging in Cannabis Use: A Review
Quickfall and Crockford
J. Neuropsychiatry Clin. Neurosi. 2006;18:318-332.
ABSTRACT | FULL TEXT  

Cannabis use by children and young people.
McArdle
Arch. Dis. Child. 2006;91:692-695.
ABSTRACT | FULL TEXT  

Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans
Kedzior and Martin-Iverson
J Psychopharmacol 2006;20:471-484.
ABSTRACT  

Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation
Chang et al.
Brain 2006;129:1096-1112.
ABSTRACT | FULL TEXT  

Neuropsychological deficits in long-term frequent cannabis users
Messinis et al.
Neurology 2006;66:737-739.
ABSTRACT | FULL TEXT  

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
Gouzoulis-Mayfrank and Daumann
J Psychopharmacol 2006;20:188-193.
ABSTRACT  

Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls
Lamers et al.
J Psychopharmacol 2006;20:302-311.
ABSTRACT  

Cannabis use, cognitive performance and mood in a sample of workers
Wadsworth et al.
J Psychopharmacol 2006;20:14-23.
ABSTRACT  

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog et al.
Neurology 2005;65:812-819.
ABSTRACT | FULL TEXT  

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects
Parrott et al.
J Psychopharmacol 2004;18:572-576.
 

Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients
Jockers-ScheruBl et al.
J Psychopharmacol 2003;17:439-445.
ABSTRACT  

Drug Addiction
Cami and Farre
NEJM 2003;349:975-986.
FULL TEXT  

Substance-Related Disorders
Mack and Frances
Focus 2003;1:125-146.
ABSTRACT | FULL TEXT  

Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus
Derkinderen et al.
J. Neurosci. 2003;23:2371-2382.
ABSTRACT | FULL TEXT  

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter et al.
J. Neurosci. 2003;23:1398-1405.
ABSTRACT | FULL TEXT  

Escalation of Drug Use in Early-Onset Cannabis Users vs Co-twin Controls
Lynskey et al.
JAMA 2003;289:427-433.
ABSTRACT | FULL TEXT  

Dose-related neurocognitive effects of marijuana use
Bolla et al.
Neurology 2002;59:1337-1343.
ABSTRACT | FULL TEXT  

Does Marijuana Use Cause Long-term Cognitive Deficits?
Gunderson et al.
JAMA 2002;287:2652-2654.
FULL TEXT  

Long-Term Cannabis Use Impairs Cognition
JWatch Emergency Med. 2002;2002:12-12.
FULL TEXT  

Cannabis Use Linked with Cognitive Impairment
Journal Watch Dermatology 2002;2002:15-15.
FULL TEXT  

Cannabis and Cognition
JWatch Psychiatry 2002;2002:6-6.
FULL TEXT  

Cognitive Performance in Long-Term Marijuana Users
JWatch Neurology 2002;2002:3-3.
FULL TEXT  

Cannabis Use Linked with Cognitive Impairment
JWatch General 2002;2002:3-3.
FULL TEXT  

Cannabis, Cognition, and Residual Confounding
Pope
JAMA 2002;287:1172-1174.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.